Prognos Health is an AI-driven platform company focused on predicting the trajectory of disease to drive decisions earlier in healthcare. Our clients are industry leading Payers, Life Sciences, and Laboratory Testing organizations. The Prognos Registry is the largest source of clinical diagnostics information in 50 disease areas, with over 25 billion medical records for 215 million patients. Prognos Health has more than 1,000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $42M investment from Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments. For more information, visit www.prognoshealth.com